Sunday, September 30, 2012

Heart Attacks: Call 9-1-1 in the USA


In the USA, Heart Disease and Stroke are the #1 and #3 killers.

Every 37 seconds, someone dies of cardiovascular disease.  

You are more likely to survive a heart attack if you know the signs and symptoms:

*    Chest Pain 
*    Shortness of Breath
*    Weakness, feeling faint, or light-headed
*    Pain in the jaw, neck, or upper back
*    Pain in the arm or shoulder, usually on one side.


Your chance of survival is directly related to how fast you get treatment.

You may need aspirin, a defibrillator, oxygen, morphine, and a blood thinner.

So Call 9-1-1 if you or someone you know has the signs and symptoms of a heart attack.  








Medical Disclaimer: Nothing on this website is meant to diagnose, treat, or practice medicine. You must be seen in person by a physician for appropriate and individual medical treatment. If you have an emergency, call 9-1-1 in the USA.

Link Disclaimer: We are not responsible for any links that go outside of this website.

Full Disclosure: Margaret A. Ferrante, M.D. was an Institute Physician with Cenegenics Medical Institute.  


What is the Low-Glycemic Index Diet?

by Dr. Margaret Aranda



While the low-glycemic index diet and was first described in 1981, its popularity began to abound in the 1990's.  Here it is now 2012, and we estimate that millions of men have not heard of it.  We hope to initiate change in this matter, as it is time to decrease abdominal obesity, diabetes, and the attendant morbidity and mortality associated with diet as a causative factor.  

In 1981, David A. Jenkins, M.D., Ph.D., DSc.,  Department of Nutrition Sciences at Canada's University of Toronto, first published an article describing the Glycemic Index in The American Journal of Clinical Nutrition.  He then formulated the Glycemic Index (GI) food by food, with numerical values assigned (Jenkins et al, 1981) as they pertained to the consumption of sugar and more recently, a piece of white bread.


The main theory is that the Glycemic Index is simply an extension of the 1977 Fiber Hypothesis of Burkitt and Trowell, which holds that dietary fiber is absorbed slowly and may have metabolic effects that are beneficial, particularly for prevention of diabetes and cardiac disease.

In the 1990's, the concepts of central abdominal adiposity and metabolic syndrome (Bjorntorp, 1992), intraabdominal fat, high waist:hip ratio (Landin et al, 1990), and insulin resistance (Vague and Raccah, 1992) were also being formed.  Foods that lead to a higher blood glucose and insulin level have a higher numerical GI value.  This numerical system is essential to decreasing the physiologic response, and to the prevention and treatment of diabetes and other chronic diseases.   Charting can be done by GI itself as a numerical value, or by grouping the Category of GI (See Chart).

Chart. High, Medium, and Low-Glycemic Foods. 

The typical Western diet hits the body with starchy carbohydrates in the morning, in the afternoon, and again in the evening.  After eating, the blood glucose increases and to compensate, the blood insulin levels also increase.  The problem is not just the resulting hyperglycemia; it is the hyperinsulinemia also.  When insulin is chronically elevated due to a high-glycemic index diet, fat can not be utilized, the body becomes insulin-resistant, and elevated insulin levels no longer drive glucose into the cells.  Diabetes and central adiposity ensue, with the attendant increase in cardiac risk and sequelae of diabetes.

The low-glycemic index diet has been attributed with the following:

1. In healthy subjects, decreased urinary C-peptide;
2. In subjects with diabetes, decreased blood glucose levels;
3. In subjects with hyperlipidemia, decreased lipid levels;
4. Increased HDL levels (beneficial lipids);
5. Decreased risk of diabetes;
6. Decreased risk of cardiovascular events;
7. Decreased risk of colon cancer;
8. Decreased risk of breast cancer;
9. Decreased central obesity.

In Canadians with a higher GI and GL diet increased the risk of the following cancers:  
prostate, colorectal, rectal, and pancreatic cancer(  Hu J, et al, 2012).

So what about the Low Glycemic-Index Diet?  Ask your doctor if you are a good candidate for it.  If so, you may Age Healthy.
We say, "It's about time."
Stay tuned for more.


by Margaret Aranda Ferrante, M.D.



References

1. Bjorntorp P. Abdominal obesity and the metabolic syndrome.  Ann Med 1992 Dec; 24(6):465-8. Abstract

2. Burkitt DP and Trowell HC.  Dietary fibre and western diseases.  Ir Med J, 1977 June 18; 70(9):272-7. Medline

3. Hu J, et al, the Canadian Cancer Registries Epidemiology Research Group.  Glycemic index, glycemic load and cancer risk.  Ann Oncol.  July 25. (Epub ahead of print).  Medline

4. Jenkins DJ, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange.  Am J Clin Nutr.  34; 362-366.

5. Jenkins DA, et al.  Glycemic index: overview of implications in health and disease.  Am J Clin Nutr 2002 July; 76(1):266S-73S.  View Full Article Here

6. Landin K, et al.  Increased insulin resistance and fat cell lipolysis in obese but not lean women with a high waist/hip ratio.  Eur J Clin Invest. 1990 Oct;20(5):530-5. Medline

7. Mehrabani HH et al.  Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study. J Am Coll Nutr.  2012 Apr;31(2):117-25. Medline

8. Vague P and Raccah D. The syndrome of insulin resistance.  Horm Res  1992;38:28-32.





Medical Disclaimer: Nothing on this website is meant to diagnose, treat, or practice medicine. You must be seen in person by a physician for appropriate and individual medical treatment. If you have an emergency, call 9-1-1 in the USA.

Link Disclaimer: We are not responsible for any links that go outside of this website.

Full Disclosure: Margaret A. Ferrante, M.D.  was an Institute Physician with Cenegenics Medical Institute.  







































 2002 Jul;76(1):266S-73S. 

The Prostate: Genetic Marker in the News

by Margaret Aranda, MD, Ph.D.

Yesterday I met Karim Kadir, M.D., Ph.D., who has studied, lectured, and been dedicated to assisting in the early diagopsis of severe prostate cancer.  He and his Team have authored many papers, researched the field, reviewed the literature, written National Institues of Health (NIH) Grants, and are now novel scientists in their own right, in the forefront of prostate cancer markers.

Prostate cancer is probably "the" most "genetic" cancer of all time and this evolving, simple test has the potential to revolutionize the future of prostate health care, in my opinion.  One of six males will end up with prostate cancer, and the old stand-by, current test, the prostate-specific antigen (PSA), is well-known for being neither sensitive nor specific to determine whether prostate cancer has occurred. 

Through single polymerase nuceotide and genetic mapping techniques, it seems that Kadir et al have the first biological marker that can determine, from a genetic basis, whether severe prostate cancer will be likely to occur in a man.  This test may be performed from a single cheek swab on a male, even at birth or infancy.  This is possible because the DNA and the genetic makeup of a male is already determined at birth.

Perhaps two years in the making, keep your eyes out for this one.  What a robust marker this could be to determine who may have the genetically disposition for severe prostate cancer.


References:

1.  A. Karim Kadir, M.D., Ph.D. View Here

2.   Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk of prostate cancer.  Prostate 2011 March 1: 71(4):421-430.
View Article Here

3.  Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables on 5,895 prostate cancer patients. Prostate 20009 August 1: 69(11):1195-1205.
View Article Here

4. Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic variation.  Prostate 2010 December 1: 70(16):1729-1738.
View Article Here

5. Curriculum Vitae, A. Karim Kadir, M.D., Ph. D. View CV Here






Medical Disclaimer: Nothing on this website is meant to diagnose, treat, or practice medicine. You must be seen in person by a physician for appropriate and individual medical treatment. If you have an emergency, call 9-1-1 in the USA.

Link Disclaimer: We are not responsible for any links that go outside of this website.

Full Disclosure: Margaret A. Ferrante, M.D.  is an Institute Physician with Cenegenics Medical Institute.  She receives no monetary compensation for hosting this website you are on, which is independent and not affiliated with Cenegenics. The information presented is for education and awareness.  Dr. Ferrante currently sees patients out of the Cenegenics office in Beverly Hills, CA. 
To book an appointment for a free Consultation, please email her at: mferrante@cenegenics.com